 |
|
|
| |
SAPPHIRE-I: PHASE 3 PLACEBO-CONTROLLED STUDY OF INTERFERON-FREE, 12-WEEK REGIMEN OF ABT-450/r/ABT-267, ABT-333, AND RIBAVIRIN IN 631 TREATMENT-NAĻVE ADULTS WITH HEPATITIS C VIRUS GENOTYPE 1
|
| |
| |
Reported by Jules Levin
EASL 2014 April 9-13 London, UK
Jordan J. Feld, Kris V. Kowdley, Eoin Coakley, Samuel Sigal, David Nelson, Darrell Crawford, Ola Weiland, Humberto Aguilar, Junyuan Julia Xiong, Barbara DaSilva-Tillmann, Lois Larsen, Thomas Podsadecki
|
| |
|
|
|
|
|
